These results show that APN regulates PP2Cm and the blood level of BCAAs; on clinical grounds, they suggest that APN may pharmacologically improve BCAA catabolism in patients with T2D [52]. The gene discussed is PPM1K; the disease is type 2 diabetes mellitus.